Literature DB >> 22959763

Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation.

Steve N Caritis1, Hyagriv N Simhan, Yuan Zhao, Dwight J Rouse, Alan M Peaceman, Anthony Sciscione, Catherine Y Spong, Michael W Varner, Fergal D Malone, Jay D Iams, Brian M Mercer, John M Thorp, Yoram Sorokin, Marshall Carpenter, Julie Lo, Susan M Ramin, Margaret Harper.   

Abstract

OBJECTIVE: We sought to evaluate in women with twin gestation the relationship between 17-hydroxyprogesterone caproate (17-OHPC) concentration and gestational age at delivery and select biomarkers of potential pathways of drug action. STUDY
DESIGN: Blood was obtained between 24-28 weeks (epoch 1) and 32-35 weeks (epoch 2) in 217 women with twin gestation receiving 17-OHPC or placebo. Gestational age at delivery and concentrations of 17-OHPC, 17-hydroxyprogesterone, progesterone, C-reactive protein (CRP), and corticotrophin-releasing hormone were assessed.
RESULTS: Women with higher concentrations of 17-OHPC delivered at earlier gestational ages than women with lower concentrations (P < .001). Women receiving 17-OHPC demonstrated significantly higher (P = .005) concentrations of CRP in epoch 1 than women receiving placebo but CRP values were similar in epoch 2 in both groups. A highly significant (P < .0001) positive relationship was observed between 17-OHPC concentration and progesterone and 17-hydroxyprogesterone concentrations at both epochs. Corticotropin-releasing hormone concentrations did not differ by treatment group.
CONCLUSION: 17-OHPC may adversely impact gestational age at delivery in women with twin gestation.
Copyright © 2012 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22959763      PMCID: PMC3484214          DOI: 10.1016/j.ajog.2012.08.001

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

1.  A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins.

Authors:  Dwight J Rouse; Steve N Caritis; Alan M Peaceman; Anthony Sciscione; Elizabeth A Thom; Catherine Y Spong; Michael Varner; Fergal Malone; Jay D Iams; Brian M Mercer; John Thorp; Yoram Sorokin; Marshall Carpenter; Julie Lo; Susan Ramin; Margaret Harper; Garland Anderson
Journal:  N Engl J Med       Date:  2007-08-02       Impact factor: 91.245

2.  Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy.

Authors:  A L Hartikainen-Sorri; A Kauppila; R Tuimala
Journal:  Obstet Gynecol       Date:  1980-12       Impact factor: 7.661

3.  Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation.

Authors:  Steve N Caritis; Shringi Sharma; Raman Venkataramanan; Dwight J Rouse; Alan M Peaceman; Anthony Sciscione; Catherine Y Spong; Michael W Varner; Fergal D Malone; Jay D Iams; Brian M Mercer; John M Thorp; Yoram Sorokin; Marshall Carpenter; Julie Lo; Susan Ramin; Margaret Harper
Journal:  Am J Obstet Gynecol       Date:  2011-03-22       Impact factor: 8.661

Review 4.  Neuroendocrine mechanisms in pregnancy and parturition.

Authors:  Felice Petraglia; Alberto Imperatore; John R G Challis
Journal:  Endocr Rev       Date:  2010-07-14       Impact factor: 19.871

5.  High-risk prematurity--progestin treatment and steroid studies.

Authors:  J W Johnson; P A Lee; A S Zachary; S Calhoun; C J Migeon
Journal:  Obstet Gynecol       Date:  1979-10       Impact factor: 7.661

6.  Simultaneous quantitation of 17alpha-hydroxyprogesterone caproate, 17alpha-hydroxyprogesterone and progesterone in human plasma using high-performance liquid chromatography-mass spectrometry (HPLC-MS/MS).

Authors:  Shimin Zhang; Sripal Reddy Mada; Shringi Sharma; Marilyn Torch; Don Mattison; Steve Caritis; Raman Venkataramanan
Journal:  J Pharm Biomed Anal       Date:  2008-08-29       Impact factor: 3.935

7.  Corticotrophin-releasing hormone (CRH)-binding protein interference with CRH antibody binding: implications for direct CRH immunoassay.

Authors:  E A Linton; A V Perkins; P Hagan; S Poole; A F Bristow; F Tilders; R Corder; C D Wolfe
Journal:  J Endocrinol       Date:  1995-07       Impact factor: 4.286

8.  Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.

Authors:  Paul J Meis; Mark Klebanoff; Elizabeth Thom; Mitchell P Dombrowski; Baha Sibai; Atef H Moawad; Catherine Y Spong; John C Hauth; Menachem Miodovnik; Michael W Varner; Kenneth J Leveno; Steve N Caritis; Jay D Iams; Ronald J Wapner; Deborah Conway; Mary J O'Sullivan; Marshall Carpenter; Brian Mercer; Susan M Ramin; John M Thorp; Alan M Peaceman; Steven Gabbe
Journal:  N Engl J Med       Date:  2003-06-12       Impact factor: 91.245

Review 9.  Potential use of C-reactive protein determinations in obstetrics and gynecology.

Authors:  P Chaisilwattana; G R Monif
Journal:  Obstet Gynecol Surv       Date:  1989-05       Impact factor: 2.347

10.  Identification of enzymes involved in the metabolism of 17alpha-hydroxyprogesterone caproate: an effective agent for prevention of preterm birth.

Authors:  Shringi Sharma; Junhai Ou; Stephen Strom; Don Mattison; Steve Caritis; Raman Venkataramanan
Journal:  Drug Metab Dispos       Date:  2008-06-23       Impact factor: 3.922

View more
  12 in total

Review 1.  Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.

Authors:  Jodie M Dodd; Rosalie M Grivell; Cecelia M OBrien; Therese Dowswell; Andrea R Deussen
Journal:  Cochrane Database Syst Rev       Date:  2017-10-31

Review 2.  What we have learned about the role of 17-alpha-hydroxyprogesterone caproate in the prevention of preterm birth.

Authors:  Steve N Caritis; Maisa N Feghali; William A Grobman; Dwight J Rouse
Journal:  Semin Perinatol       Date:  2016-04-19       Impact factor: 3.300

Review 3.  Prevention of preterm delivery with 17-hydroxyprogesterone caproate: pharmacologic considerations.

Authors:  Maisa Feghali; Raman Venkataramanan; Steve Caritis
Journal:  Semin Perinatol       Date:  2014-09-23       Impact factor: 3.300

4.  Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth.

Authors:  Steve N Caritis; Raman Venkataramanan; Elizabeth Thom; Margaret Harper; Mark A Klebanoff; Yoram Sorokin; John M Thorp; Michael W Varner; Ronald J Wapner; Jay D Iams; Marshall W Carpenter; William A Grobman; Brian M Mercer; Anthony Sciscione; Dwight J Rouse; Susan Ramin
Journal:  Am J Obstet Gynecol       Date:  2013-10-07       Impact factor: 8.661

5.  Qualitative and quantitative measures of various compounded formulations of 17-alpha hydroxyprogesterone caproate.

Authors:  Steve N Caritis; Yang Zhao; Joseph Bettinger; Raman Venkataramanan
Journal:  Am J Obstet Gynecol       Date:  2013-02-20       Impact factor: 8.661

Review 6.  Basic obstetric pharmacology.

Authors:  Yang Zhao; Mary F Hebert; Raman Venkataramanan
Journal:  Semin Perinatol       Date:  2014-10-01       Impact factor: 3.300

Review 7.  17-Hydroxyprogesterone caproate in triplet pregnancy: an individual patient data meta-analysis.

Authors:  C A Combs; E Schuit; S N Caritis; A C Lim; T J Garite; K Maurel; D Rouse; E Thom; A T Tita; Bwj Mol
Journal:  BJOG       Date:  2015-12-10       Impact factor: 6.531

Review 8.  Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis.

Authors:  E Schuit; S Stock; L Rode; D J Rouse; A C Lim; J E Norman; A H Nassar; V Serra; C A Combs; C Vayssiere; M M Aboulghar; S Wood; E Çetingöz; C M Briery; E B Fonseca; K Worda; A Tabor; E A Thom; S N Caritis; J Awwad; I M Usta; A Perales; J Meseguer; K Maurel; T Garite; M A Aboulghar; Y M Amin; S Ross; C Cam; A Karateke; J C Morrison; E F Magann; K H Nicolaides; N P A Zuithoff; R H H Groenwold; K G M Moons; A Kwee; B W J Mol
Journal:  BJOG       Date:  2014-08-22       Impact factor: 6.531

9.  Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.

Authors:  Jodie M Dodd; Rosalie M Grivell; Cecelia M OBrien; Therese Dowswell; Andrea R Deussen
Journal:  Cochrane Database Syst Rev       Date:  2019-11-20

Review 10.  Bridging progestogens in pregnancy and pregnancy prevention.

Authors:  Elizabeth Micks; Greta B Raglan; Jay Schulkin
Journal:  Endocr Connect       Date:  2015-12       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.